• Delphine AGUILÉRA-CARON

    General Manager

    JOHNSON & JOHNSON INNOVATIVE MEDICINE

    France

    After obtaining a degree in Marketing and Market Studies from EM Lyon Business School, Delphine joined the sales teams of Nestlé and later Colgate-Palmolive. In 2005, she continued her career at Bristol-Myers Squibb, an American biopharmaceutical company.
    In 2017, she joined Janssen as the Head of Strategy for Immunology, Cardiovascular-Metabolism, and Mature Products in Europe. Two years after joining the group, she became the Managing Director of Janssen Austria, which became the leading pharmaceutical company in the country under her leadership.
    Since September 1st, 2021, Delphine has been the President of Janssen France. She also chairs the Janssen Horizon Endowment Fund. She is a member of the Board of Directors of Leem (The French Federation of Pharmaceutical Companies) and Agipharm (American laboratories).
    In her role at Janssen France, Delphine oversees the operational challenges to continue providing state-of-the-art therapeutic innovations to patients suffering from severe diseases. She is committed to leading her teams to success while upholding the company's values and leveraging her social, societal, and environmental responsibilities.
  • 15:00DebateHealth, sobriety! Watch the replay

    Delphine AGUILÉRA-CARON
    General Manager
    JOHNSON & JOHNSON INNOVATIVE MEDICINE
    France

    Xavier CHEVAL
    President
    PRAEMIA REIM CARE
    France

    Bertrand LUKACS
    Member of the Scientific Advisory Board
    HEALTH DATA HUB
    France

    Delphine MAISONNEUVE
    CEO
    GROUPE VYV
    France

    Frédéric VARNIER
    General Manager
    CHU CAEN
    France

    Led by:

    Jean-David ZEITOUN
    Physician; Founder
    INATO
    France